Labcorp (LH) Stock Price, Fundamentals & Analysis

What LH does

Labcorp (LH) is a US stock in the Healthcare sector, operating in the Diagnostics & Research industry. The company provides laboratory services through two segments: Diagnostics Laboratories and Biopharma Laboratory Services. Its offerings range from routine blood chemistry and urinalyses to specialized testing in areas such as anatomic pathology/oncology, cardiovascular disease, pharmacogenetics, and occupational testing. Headquartered in Burlington, United States, it employs 71,000 people.

Key numbers explained

• The current price of 303,98 USD reflects the latest trading value; the -2.43% price change today shows the session’s move.
• The trailing P/E ratio of 25.9 compares the share price to the last twelve months of earnings (11.75 USD per share), indicating how much investors pay per dollar of recent earnings.
• The forward P/E ratio of 15.3 uses expected future earnings, often viewed as a more forward-looking valuation measure.
• The dividend yield of 0.92% represents the annual dividend as a percentage of the current price; the ex-dividend date is 28 aug. 2026 and 24% of earnings are paid out as dividends.
• The beta of 0.85 suggests the stock has historically moved less than the overall market.
• The 11.5% price change over the last 52 weeks (from 244,52 to 341,8) shows the range and one-year return.
• The debt-to-equity ratio of 79.1% indicates the level of debt relative to shareholders’ equity.
• Labcorp is part of the S&P 500, a broad US equity index.

Recent news

Recent headlines indicate that Labcorp is planning acquisitions and lab technology investment following its 2026 Investor Day. Other coverage questions whether the stock is outperforming the Dow and notes a recent drop in its share price, while the company reaffirmed its long-term earnings outlook.

What to watch

For a stock like Labcorp, investors typically monitor earnings releases and guidance updates, such as the upcoming report on 27 oct. 2026. The healthcare and diagnostics sectors can be affected by regulatory changes, reimbursement policies, and technological advances in laboratory testing. Broader market conditions, interest rates, and the performance of peers such as Cooper Companies (The) (COO), Danaher Corporation (DHR), Waters Corporation (WAT), Medtronic (MDT), Johnson & Johnson (JNJ), Edwards Lifesciences (EW), and Henry Schein (HSIC) can also influence sentiment. For a full list of available stocks, see the Stocks directory.